Fundies.
English

Segment disclosures

Company overview

티앤알바이오팹

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

1 dimension combinations 16 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Consolidated

Consolidated And Separate Financial Statements

Source dimensions ifrs-full:ConsolidatedAndSeparateFinancialStatementsAxis=ifrs-full:ConsolidatedMember
PeriodValueUnitFiledEvidence
2026-04-01 – 2026-06-309535077986 KRW20260831Open filing evidence
2026-01-01 – 2026-06-3018256566625 KRW20260831Open filing evidence
2026-01-01 – 2026-03-318721488639 KRW20260825Open filing evidence
2025-01-01 – 2025-12-3126967256198 KRW20260825Open filing evidence
2025-07-01 – 2025-09-306954144054 KRW20251201Open filing evidence
2025-01-01 – 2025-09-3019445707428 KRW20251201Open filing evidence
2025-04-01 – 2025-06-306536306056 KRW20260831Open filing evidence
2025-01-01 – 2025-06-3012491563374 KRW20260831Open filing evidence
2025-01-01 – 2025-03-315955257318 KRW20260825Open filing evidence
2024-01-01 – 2024-12-314873728487 KRW20260825Open filing evidence
2024-07-01 – 2024-09-301096619832 KRW20251201Open filing evidence
2024-01-01 – 2024-09-303644572546 KRW20251201Open filing evidence
2024-04-01 – 2024-06-301360461106 KRW20250821Open filing evidence
2024-01-01 – 2024-06-302547952714 KRW20250821Open filing evidence
2024-01-01 – 2024-03-311187491608 KRW20250616Open filing evidence
2023-01-01 – 2023-12-315199194463 KRW20260825Open filing evidence